Literature DB >> 21213002

In silico study on the substrate binding manner in human myo-inositol monophosphatase 2.

Seisuke Fujita1, Tetsuo Ohnishi, Shujiro Okuda, Ryo Kobayashi, Satoshi Fukuno, Daisuke Furuta, Takeshi Kikuchi, Takeo Yoshikawa, Norihisa Fujita.   

Abstract

The human IMPA2 gene encoding myo-inositol monophosphatase 2 is highly implicated with bipolar disorder but the substrates and the reaction mechanism of myo-inositol monophosphatase 2 have not been well elucidated.9 In the present study, we constructed 3D models of three- and two-Mg(2+)-ion bound myo-inositol monophosphatase 2, and studied substrate-binding manners using the docking program AutoDock3. The subsequent study showed that the three-metal-ion model could interact with myo-inositol monophosphates, as follows: The phosphate moiety coordinated three Mg(2+) ions, and the inositol ring formed hydrogen bonds with the amino acids conserved in the family. Furthermore, the OH group vicinal to the phosphate group formed a hydrogen bond with a non-bridging oxygen atom of the phosphate. These interactions have been proposed as crucial for forming the transitional state, bipyramidal structure in the bovine myo-inositol monophosphatase. We therefore propose that the human myo-inositol monophosphatase 2 interacts with myo-inositol monophosphates in the three-metal-ion bound form, and proceeds the dephosphorylation through the three-metal-ion theory.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21213002     DOI: 10.1007/s00894-010-0937-8

Source DB:  PubMed          Journal:  J Mol Model        ISSN: 0948-5023            Impact factor:   1.810


  29 in total

1.  A promoter haplotype of the inositol monophosphatase 2 gene (IMPA2) at 18p11.2 confers a possible risk for bipolar disorder by enhancing transcription.

Authors:  Tetsuo Ohnishi; Kazuo Yamada; Hisako Ohba; Yoshimi Iwayama; Tomoko Toyota; Eiji Hattori; Toshiya Inada; Hiroshi Kunugi; Masahiko Tatsumi; Norio Ozaki; Nakao Iwata; Kaoru Sakamoto; Yoshimi Iijima; Yasuhide Iwata; Kenji J Tsuchiya; Genichi Sugihara; Shinichiro Nanko; Noriko Osumi; Sevilla D Detera-Wadleigh; Tadafumi Kato; Takeo Yoshikawa
Journal:  Neuropsychopharmacology       Date:  2007-01-24       Impact factor: 7.853

2.  Modification of myo-inositol monophosphatase by the arginine-specific reagent phenylglyoxal.

Authors:  R G Jackson; N S Gee; C I Ragan
Journal:  Biochem J       Date:  1989-12-01       Impact factor: 3.857

3.  The 6-OH group of D-inositol 1-phosphate serves as an H-bond donor in the catalytic hydrolysis of the phosphate ester by inositol monophosphatase.

Authors:  D J Miller; M W Beaton; J Wilkie; D Gani
Journal:  Chembiochem       Date:  2000-11-17       Impact factor: 3.164

4.  Evaluation of linkage of bipolar affective disorder to chromosome 18 in a sample of 57 German families.

Authors:  M M Nöthen; S Cichon; H Rohleder; S Hemmer; E Franzek; J Fritze; M Albus; M Borrmann-Hassenbach; R Kreiner; B Weigelt; J Minges; D Lichtermann; W Maier; N Craddock; R Fimmers; T Höller; M P Baur; M Rietschel; P Propping
Journal:  Mol Psychiatry       Date:  1999-01       Impact factor: 15.992

5.  Purification and properties of myo-inositol-1-phosphatase from bovine brain.

Authors:  P V Attwood; J B Ducep; M C Chanal
Journal:  Biochem J       Date:  1988-07-15       Impact factor: 3.857

6.  Bovine inositol monophosphatase. Studies on the binding interactions with magnesium, lithium and phosphate ions.

Authors:  P J Greasley; M G Gore
Journal:  FEBS Lett       Date:  1993-09-27       Impact factor: 4.124

7.  The effects of lithium ion and other agents on the activity of myo-inositol-1-phosphatase from bovine brain.

Authors:  L M Hallcher; W R Sherman
Journal:  J Biol Chem       Date:  1980-11-25       Impact factor: 5.157

Review 8.  Structure and mechanism of inositol monophosphatase.

Authors:  J R Atack; H B Broughton; S J Pollack
Journal:  FEBS Lett       Date:  1995-03-13       Impact factor: 4.124

9.  Examination of IMPA1 and IMPA2 genes in manic-depressive patients: association between IMPA2 promoter polymorphisms and bipolar disorder.

Authors:  G Sjøholt; R P Ebstein; R T Lie; J Ø Berle; J Mallet; J F Deleuze; D F Levinson; C Laurent; M Mujahed; I Bannoura; I Murad; A Molven; V M Steen
Journal:  Mol Psychiatry       Date:  2004-06       Impact factor: 15.992

10.  Dimerization of inositol monophosphatase Mycobacterium tuberculosis SuhB is not constitutive, but induced by binding of the activator Mg2+.

Authors:  Alistair K Brown; Guoyu Meng; Hemza Ghadbane; David J Scott; Lynn G Dover; Jérôme Nigou; Gurdyal S Besra; Klaus Fütterer
Journal:  BMC Struct Biol       Date:  2007-08-28
View more
  2 in total

1.  Defective craniofacial development and brain function in a mouse model for depletion of intracellular inositol synthesis.

Authors:  Tetsuo Ohnishi; Takuya Murata; Akiko Watanabe; Akiko Hida; Hisako Ohba; Yoshimi Iwayama; Kazuo Mishima; Yoichi Gondo; Takeo Yoshikawa
Journal:  J Biol Chem       Date:  2014-02-19       Impact factor: 5.157

2.  IMPA2 polymorphisms and risk of ischemic stroke in a northwest Han Chinese population.

Authors:  Qiaoya Ma; Ying Yang; Yuyan Na; Tianbo Jin; Yidong Xue; Yuting Shi; Chen Li; Wanggang Zhang
Journal:  Oncotarget       Date:  2016-11-15
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.